CD276 and non-small cell lung carcinoma: The overexpression of epidermal growth factor receptor (EGFR) and B7 homolog 3 protein (B7H3) are known to drive the growth and proliferation of non-small cell lung cancer (NSCLC), thereby positioning them as promising therapeutic targets.